Genetically modified mammalian cells are the preferred system for the produ
ction of recombinant therapeutic glycoproteins. Other applications include
engineering of cell lines for drug screening and cell-based therapies, and
the construction of recombinant viruses for gene therapy. This article high
lights contemporary core genetic technologies and emerging strategies for g
enetically engineering mammalian cells for optimal recombinant-protein expr
ession.